GH
IONS icon

GAM Holding’s Ionis Pharmaceuticals IONS Stock Holding History

GAM Holding’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,727
Closed -$180K – 956
2016
Q2 		$180K Buy
7,727
+4,191
+119% +$135K ﹤0.01% 909
2016
Q1 		$143K Hold
3,536
– – ﹤0.01% 903
2015
Q4 		$219K Buy
3,536
+956
+37% +$51.6K ﹤0.01% 998
2015
Q3 		$104K Hold
2,580
– – ﹤0.01% 1060
2015
Q2 		$148K Buy
2,580
+780
+43% +$49.6K ﹤0.01% 1053
2015
Q1 		$115K Buy
+1,800
New +$122K ﹤0.01% 1014

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GAM Holding's IONS Position: Q3 2016 in Review

GAM Holding sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 7,727 shares — an estimated $180K sold.

GAM Holding first reported a position in IONS in Q1 2015 and held it in 6 quarters. The position peaked at $219K in Q4 2015. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

  • GAM Holding reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • GAM Holding sold 7,727 Ionis Pharmaceuticals shares in Q3 2016, an estimated $180K.
  • GAM Holding first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 6 quarters.
  • GAM Holding's Ionis Pharmaceuticals position peaked at $219K in Q4 2015.
  • 281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on GAM Holding's 13F filing for Q3 2016, filed 7 Nov 2016.